Knockout/knockin and lentivral mice

Ended Definitive Contract Awarded Last action

Contract number
HHSN272200400013C
Awardee
Awarding agency
Obligated
$3,434,656

Award facts

Contract value 9% obligated
  • $9,886,655.78 Current, with exercised options
  • $38,945,214.78 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
112990 All Other Animal Production
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers
Pricing
Firm Fixed Price
Place of performance
Australia

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 54 · Final_close_process -final_close_process -final_close_process - -$55,379
Other Administrative Action 53 $0
Other Administrative Action 52 · Final_close_process -final_close_process - -$67,759
Other Administrative Action 50 · Miscellaneous items $0
Other Administrative Action 51 · Final_close_process - -$1
Supplemental Agreement for work within scope 49 $0
Supplemental Agreement for work within scope 48 · Miscellaneous items $51,600
Supplemental Agreement for work within scope 47 $10,551
Supplemental Agreement for work within scope 46 $18,228
Supplemental Agreement for work within scope 45 $213,152
Supplemental Agreement for work within scope 44 $64,600
Supplemental Agreement for work within scope 43 $621
Supplemental Agreement for work within scope 42 $10,649
Supplemental Agreement for work within scope 41 $61,000
Exercise an Option 40 $0
Supplemental Agreement for work within scope 39 $15,570
Supplemental Agreement for work within scope 38 $39,056
Supplemental Agreement for work within scope 37 $63,335
Supplemental Agreement for work within scope 36 $6,349
Supplemental Agreement for work within scope 35 $167,577
Supplemental Agreement for work within scope 34 $62,202
Supplemental Agreement for work within scope 33 $24,164
Supplemental Agreement for work within scope 32 $366,000
Supplemental Agreement for work within scope 31 $2,695
Other Administrative Action 30 $0
Exercise an Option 29 $0
Supplemental Agreement for work within scope 28 $48,571
Supplemental Agreement for work within scope 27 $67,400
Supplemental Agreement for work within scope 26 $8,669
Funding Only Action 25 $23,275
Funding Only Action 24 $5,819
Supplemental Agreement for work within scope 23 $113,933
Supplemental Agreement for work within scope 22 $184,562
Supplemental Agreement for work within scope 21 $5,000
Funding Only Action 20 $88,115
Funding Only Action 19 $26,974
Exercise an Option 18 $0
Exercise an Option 17 $109,800
Other Administrative Action 16 $0
Funding Only Action 15 $0
Other Administrative Action 14 $0
Funding Only Action 13 $149,700
Funding Only Action 12 $74,800
Funding Only Action 11 $149,800
Funding Only Action 10 $89,357
Change Order 9 $124,730
Funding Only Action 8 $68,412
Exercise an Option 7 $109,800
Change Order 6 $109,800
Change Order 5 $327,829
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

About this award

This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development, thyroid hormone signaling, and diabetes. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), National Heart Lung and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and National Institute of Child Health and Human Development (NICHD), and has a firm fixed price with a final completion date of January 2, 2014. The contract was not set aside and Ozgene PTY LTD is the prime contractor with no major subcontractors identified.

Quick answers

Who was awarded contract HHSN272200400013C?

HHSN272200400013C was awarded to Ozgene PTY LTD by NIAID DEA OA Acquisitions (National Institutes of Health) on March 1, 2004.

How much is contract HHSN272200400013C worth?

The government has obligated $3,434,656 on HHSN272200400013C. Its current value, with exercised options, is $9,886,656. Its potential value, with all options, is $38,945,215.

Was contract HHSN272200400013C competed?

The extent of competition for HHSN272200400013C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award